Brodkey Amy C
University of Pennsylvania Medical School, Philadelphia, USA.
Acad Psychiatry. 2005 May-Jun;29(2):222-9. doi: 10.1176/appi.ap.29.2.222.
To describe and examine the role of the pharmaceutical industry in the teaching of psychopharmacology to residents and medical students and to make recommendations for changes in curriculum and policy based on these findings.
Literature reviews and discussions with experts, educators, and trainees.
The pharmaceutical industry currently plays an extensive role in teaching psychopharmacology to trainees, both directly and indirectly. Attendance at industry-sponsored lectures and drug lunches, meetings with pharmaceutical representatives, and interactions involving the acceptance of various gifts are the most obvious venues. Less apparent but equally pervasive are the influence of industry-sponsored faculty and research and industry's effect on the climate of practice and the profession as a whole. Replacing medical education with industry promotion in the guise of scholarship causes demonstrable harm to trainees, the public, and the profession.
In light of these findings, the medical profession must reassert control of medical education and draw a firm barrier between commercial and professional pursuits. These issues must be actively, explicitly, and rigorously discussed with our colleagues and students.
描述并审视制药行业在向住院医师和医学生传授精神药理学知识方面所扮演的角色，并基于这些研究结果就课程设置和政策变革提出建议。
文献综述以及与专家、教育工作者和学员进行讨论。
制药行业目前在直接和间接地向学员传授精神药理学知识方面发挥着广泛作用。参加行业赞助的讲座和药品午餐会、与制药代表会面以及接受各种礼品的互动是最明显的途径。不太明显但同样普遍存在的是行业赞助的师资力量和研究的影响，以及行业对整体执业环境和职业的影响。以学术之名用行业推广取代医学教育会对学员、公众和整个职业造成明显伤害。
鉴于这些研究结果，医学界必须重新掌控医学教育，并在商业追求和专业追求之间划清明确界限。必须与我们的同事和学生积极、明确且严格地讨论这些问题。
